Review of fesoterodine

@article{Vella2011ReviewOF,
  title={Review of fesoterodine},
  author={Maria Vella and L. Cardozo},
  journal={Expert Opinion on Drug Safety},
  year={2011},
  volume={10},
  pages={805 - 808}
}
Introduction: Overactive bladder syndrome is a common condition that adversely affects the quality of life. It is mainly treated with a combination of bladder retraining and antimuscarinics. In a quest to reduce the side effect profile of these drugs, whilst improving their efficacy, more bladder-selective antimuscarinics were developed. One of the more recent of these antimuscarinics which has come to the market is fesoterodine. This review examines the evidence of the safety and efficacy of… Expand
6 Citations
Fesoterodine fumarate and the oxybutynin ring for the treatment of urinary incontinence in women
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females
  • 27
Overactive bladder – 18 years – Part II
  • J. Truzzi, C. Gomes, +24 authors R. Reges
  • Medicine
  • International braz j urol : official journal of the Brazilian Society of Urology
  • 2016
  • 9
  • PDF
Overactive bladder – 18 years – part I
  • J. Truzzi, C. Gomes, +24 authors R. Reges
  • Medicine
  • International braz j urol : official journal of the Brazilian Society of Urology
  • 2016
  • 10
  • PDF

References

SHOWING 1-10 OF 16 REFERENCES
Fesoterodine, an advanced antimuscarinic for the treatment of overactive bladder: A safety update
  • 34
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
  • 179
  • Highly Influential
Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder.
  • 224
  • Highly Influential
A new questionnaire to assess the quality of life of urinary incontinent women
  • 367
...
1
2
...